Haploidentical Stem Cell Transplantation: An Emerging Treatment Modality by Taner DemirerHaploidentical Stem Cell Transplantation: An Emerging Treatment Modality by Taner Demirer

Haploidentical Stem Cell Transplantation: An Emerging Treatment Modality

byTaner Demirer

Paperback | June 12, 2018

Pricing and Purchase Info

$255.95

Earn 1,280 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

This book discusses the aspects of haploidentical transplants and will shed light on the debates and questions on this burgeoning field and timely topic. Donor selection, graft failure, minimal CD34+ cell requirement, and conditioning regimens used for haploidentical transplants will be written by expert authors dealing with this type of transplants. Approximately one third of the books' chapters cover logic and basic aspects; the remaining two thirds of the book discuss clinical aspects, outcomes, and future perspectives, thus providing a comphrensive discussion of the topic. Haploidentical transplantation is extremely timely, rapidly-changing area and increasing its use will decrease the need for time-consuming, expensive, unrelated donor search. Moreover,Haploidentical Stem Cell Transplantation brings a set of clear answers to questions of feasibility, advantages over unrelated transplants, cost effectivity and outcome.. 

Dr. Taner Demirer, MD, FACP, graduated from Ankara University Medical School in Turkey in 1984 and was trained in the USA through 1987-1997.  He completed his Internal Medicine residency at the Medical College of Wisconsin in 1989-1992 and hematology/oncology and bone marrow transplant fellowship at the University of Washington, Fred H...
Loading
Title:Haploidentical Stem Cell Transplantation: An Emerging Treatment ModalityFormat:PaperbackDimensions:199 pagesPublished:June 12, 2018Publisher:Humana PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3319879995

ISBN - 13:9783319879994

Reviews

Table of Contents

1. General Indications and Logic for Haploidentical SCT.- 2. Donor Selection and  Cell Dose in Haploidentical SCT.- 3. Graft Failure and Rejection in Haploidentical SCT.- 4. Toxicity of Conditioning Regimens in Haploidentical SCT.- 4. Toxicity of Conditioning Regimens in Haploidentical SCT.- 5. An Overview of the Prophylaxis and Treatment of GVHD in Haploidentical STC.- 6. Prevention and Treatment of Infectious Complications in Haploidentical SCT.- 7. Graft versus Leukemia (GVL), Graft versus Lymphoma Effect in Haploidentical SCT.- 8. Outcome of Haploidentical SCT in Patients with Acute Leukemia.- 9. Outcome of Haploidentical SCT in Patients with Lymphoma.- 10. Applications of Haploidentical SCT in Patients with Non-malignant Diseases.- 11. Applications of Haploidentical SCT in Pediatric Patients.- 12. Innovative Approaches in Order to Increase the Success of the Haploidentical SCT. 13. Future Perspectives for Haploidentical SCT.